T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rivian
RIVN
|
+$18.7B |
| 2 |
Apple
AAPL
|
+$5.48B |
| 3 |
NVIDIA
NVDA
|
+$5.33B |
| 4 |
Tesla
TSLA
|
+$4.47B |
| 5 |
Microsoft
MSFT
|
+$2.15B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$4.26B |
| 2 |
Meta Platforms (Facebook)
META
|
+$3.3B |
| 3 |
Morgan Stanley
MS
|
+$2.82B |
| 4 |
Global Payments
GPN
|
+$2.43B |
| 5 |
PayPal
PYPL
|
+$2B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.4% |
| 2 | Healthcare | 16.1% |
| 3 | Consumer Discretionary | 15.8% |
| 4 | Communication Services | 12.38% |
| 5 | Financials | 10.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BNR
1476
Burning Rock Biotech
BNR
$105M
| $5.65M | ﹤0.01% |
59,322
+3,874
| +7% | +$531K |
|
1477
Annaly Capital Management
NLY
$17.6B
| $5.65M | ﹤0.01% |
180,635
+35,521
| +24% | +$1.19M |
|
1478
Brinker International
EAT
$10.2B
| $5.63M | ﹤0.01% |
153,816
-152,820
| -50% | -$6.31M |
|
1479
Axalta
AXTA
$7.93B
| $5.62M | ﹤0.01% |
169,738
+6,318
| +4% | +$200K |
|
1480
Under Armour Class C
UA
$2.25B
| $5.58M | ﹤0.01% |
309,074
-11,046
| -3% | -$215K |
|
1481
Under Armour
UAA
$2.3B
| $5.55M | ﹤0.01% |
261,752
+12,286
| +5% | +$279K |
|
1482
Warner Bros
WBD
$69.6B
| $5.5M | ﹤0.01% |
233,646
-3,004
| -1% | -$74.8K |
|
1483
Badger Meter
BMI
$3.91B
| $5.36M | ﹤0.01% |
50,323
+5,435
| +12% | +$572K |
|
|
GAP
1484
The Gap Inc
GAP
$7.34B
| $5.3M | ﹤0.01% |
300,194
-3,066
| -1% | -$64.2K |
|
1485
Toronto Dominion Bank
TD
$204B
| $5.23M | ﹤0.01% |
68,094
+798
| +1% | +$58.2K |
|
1486
Lear
LEA
$8.16B
| $5.12M | ﹤0.01% |
27,978
-2,082
| -7% | -$366K |
|
1487
Nordson
NDSN
$17.3B
| $5.05M | ﹤0.01% |
19,789
-765
| -4% | -$196K |
|
|
AXON
1488
Axon Enterprise
AXON
$50B
| $5.04M | ﹤0.01% |
32,121
-1,728
| -5% | -$290K |
|
1489
Graphic Packaging
GPK
$3.46B
| $5M | ﹤0.01% |
256,404
+22,379
| +10% | +$448K |
|
1490
Gaming and Leisure Properties
GLPI
$12.5B
| $4.97M | ﹤0.01% |
102,093
-3,428
| -3% | -$163K |
|
|
OPLN
1491
Openlane
OPLN
$4.34B
| $4.89M | ﹤0.01% |
312,796
+38,244
| +14% | +$586K |
|
|
CONE
1492
DELISTED
CyrusOne Inc Common Stock
CONE
| $4.86M | ﹤0.01% |
54,117
+3,305
| +7% | +$280K |
|
1493
HNI Corp
HNI
$3.55B
| $4.85M | ﹤0.01% |
115,443
+22,171
| +24% | +$888K |
|
1494
TIM SA
TIMB
$8.69B
| $4.77M | ﹤0.01% |
410,000
-64,800
| -14% | -$735K |
|
1495
Lamar Advertising Co
LAMR
$15.8B
| $4.75M | ﹤0.01% |
39,172
-1,048
| -3% | -$122K |
|
|
GMS
1496
DELISTED
GMS Inc
GMS
| $4.73M | ﹤0.01% |
78,630
+5,899
| +8% | +$318K |
|
1497
Sprouts Farmers Market
SFM
$8.03B
| $4.72M | ﹤0.01% |
159,093
-6,548
| -4% | -$164K |
|
1498
Seres Therapeutics
MCRB
$47.4M
| $4.67M | ﹤0.01% |
28,028
-39,998
| -59% | -$6.36M |
|
1499
American Financial Group
AFG
$12B
| $4.67M | ﹤0.01% |
33,974
-2,209
| -6% | -$304K |
|
|
AVNS
1500
DELISTED
Avanos Medical
AVNS
| $4.64M | ﹤0.01% |
133,980
-2,027,116
| -94% | -$65.5M |
|
Similar funds
T. Rowe Price Associates's Q4 2021 Portfolio in Review
As of Q4 2021, T. Rowe Price Associates held 3,121 positions worth $1.11T, up 4.6% from $1.06T the previous quarter. Its ten largest holdings account for 28% of the portfolio.
T. Rowe Price Associates's Q4 2021 filing shows 186 new, 817 increased, 1,825 reduced and 148 closed positions. Its largest new stake was Rivian: 162,080,423 shares worth $16.1B. The largest sale was Visa, an estimated $4.26B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2021 buy was Rivian: 162,080,423 shares worth $16.1B.
- T. Rowe Price Associates added most to Apple in Q4 2021, an estimated $5.48B increase.
- T. Rowe Price Associates's biggest Q4 2021 reduction was Visa, cutting an estimated $4.26B.
- T. Rowe Price Associates fully exited Acceleron Pharma in Q4 2021, selling an estimated $923M.
- T. Rowe Price Associates's ten largest holdings make up 28% of its $1.11T portfolio in Q4 2021.
- T. Rowe Price Associates opened 186 new positions and closed 148 in Q4 2021.
- T. Rowe Price Associates's portfolio value rose 4.6% quarter-over-quarter to $1.11T.
Based on T. Rowe Price Associates's 13F filing for Q4 2021, filed 14 Feb 2022.